发明名称 USE OF alpha -MSH AND EPO FOR PREVENTING OR TREATING ISCHEMIC CONDITIONS
摘要 The present invention relates to a method for treating or preventing ischemia induced organ dysfunction. The method comprises administration of an effective dose of alpha -MSH and/or an alpha -MSH equivalent and EPO and/or an EPO equivalent to an individual in need thereof. Examples of ischemic conditions, which may be treated according to the present invention, are: Ischemia induced renal failure, myocardial ischemia, intestinal ischemia and cerebral ischemia. In various animal models of ischemia the combination of alpha -MSH and rh-EPO has been shown to have a synergistic effect in reversing the adverse effects of the ischemia.
申请公布号 WO0182952(A2) 申请公布日期 2001.11.08
申请号 WO2001DK00303 申请日期 2001.05.02
申请人 ACTION PHARMACEUTICALS APS;NIELSEN, SOEREN;FROEKIAER, JOERGEN;JONASSEN, THOMAS, ENGELBRECHT, NORKILD;BJERKE, THORBJOERN 发明人 NIELSEN, SOEREN;FROEKIAER, JOERGEN;JONASSEN, THOMAS, ENGELBRECHT, NORKILD;BJERKE, THORBJOERN
分类号 A61K38/22;A61K38/13;A61K38/18;A61K38/19;A61K38/20;A61K38/34;A61P1/04;A61P3/06;A61P3/10;A61P7/00;A61P7/06;A61P9/00;A61P11/02;A61P11/06;A61P17/04;A61P17/06;A61P19/02;A61P19/06;A61P19/08;A61P19/10;A61P21/00;A61P27/00;A61P27/02;A61P29/00;A61P31/04;A61P31/06;A61P31/10;A61P31/12;A61P31/18;A61P35/00;A61P35/02;A61P35/04;A61P37/02;A61P37/06 主分类号 A61K38/22
代理机构 代理人
主权项
地址